CDCNHSN
NHSN Surveillance System Codes
activeHAI2.1.0fragment131 concepts
A fragment of the set of healthcare surveillance vocabulary concepts and associated identifiers intended solely for data submissions to the National Healthcare Safety Network (NHSN). Other uses are not recommended.
The CDCNHSN code system is highly specialized to meet the needs of NHSN surveillance reporting, is undergoing changes, and is not recommended for creating value sets to be used outside of NHSN.
Metadata
hl7.org/fhir- Canonical URL
- https://www.cdc.gov/nhsn/cdaportal/terminology/codesystem/cdcnhsn.html
- ID
- CDCNHSN
- Version
- 2020-11
- Publisher
- HL7 International - Structured Documents Work Group
- Case Sensitive
- Yes
Concepts (131)
| Code | Display | Definition |
|---|---|---|
1601-4 | Breast abscess or mastitis | - |
1602-2 | Myocarditis or pericarditis | - |
1603-0 | Clinical sepsis | - |
1604-8 | Deep incisional primary surgical site infection (SSI) | - |
1605-5 | Deep incisional secondary surgical site infection (SSI) | - |
1606-3 | Vertebral disc space infection | - |
1607-1 | Ear or mastoid infection (otitis externa, otitis media, otitis interna, mastoiditis) | - |
1608-9 | Eye infection, other than conjunctivitis | - |
1609-7 | Gastrointestinal tract infection (esophagus, stomach, small and large bowel, and rectum) excluding gastroenteritis and appendicitis | - |
1610-5 | Intraabdominal infection, not specified elsewhere including gallbladder, bile ducts, liver (excluding viral hepatitis), spleen, pancreas, peritoneum, subphrenic or subdiaphragmatic space, or other intraabdominal tissue or area not specified elsewhere | - |
1611-3 | Intracranial infection (brain abscess, subdural or epidural infection, encephalitis) | - |
1612-1 | Joint or bursa infection | - |
1613-9 | Laboratory-confirmed bloodstream infection | - |
1614-7 | Other infections of lower respiratory tract, other than pneumonia | - |
1615-4 | Meningitis or ventriculitis | - |
1616-2 | Oral cavity infection (mouth, tongue, or gums) | - |
1617-0 | Other infections of the male or female reproductive tract (epididymis, testes, prostate, vagina, ovaries, uterus, or other deep pelvic tissues, excluding endometritis or vaginal cuff infections) | - |
1618-8 | Other infections of the urinary tract (kidney, ureter, bladder, urethra, or tissue surrounding the retroperitoneal or perinephric space) | - |
1619-6 | Spinal abscess without meningitis | - |
1620-4 | Superficial incisional primary surgical site infection (SSI) | - |
1621-2 | Superficial incisional secondary surgical site infection (SSI) | - |
1622-0 | Upper respiratory tract infection, pharyngitis, laryngitis, epiglottitis | - |
1623-8 | Arterial or venous infection | - |
1624-6 | Vaginal cuff infection | - |
1625-3 | Symptomatic UTI (SUTI) | - |
1626-1 | Pneumonia 1 (PNU1) | - |
1631-1 | Pneumonia 2 (PNU2) | - |
1632-9 | Pneumonia 3 (PNU3) | - |
1640-2 | Organ/space | - |
1671-7 | Bronchitis or tracheitis | - |
1672-5 | Burn infection | - |
1673-3 | Decubitus ulcer infection | - |
1674-1 | Disseminated infection | - |
1675-8 | Infant pustulosis | - |
1676-6 | Newborn circumcision infection | - |
1677-4 | Soft tissue, muscle, lymph node, or salivary gland infection | - |
1970-3 | Periprosthetic joint infection | - |
2343-4 | Ventilator-associated condition (VAC) | - |
2344-2 | Infection-related ventilator-associated complication (IVAC) | - |
2345-0 | Possible ventilator-associated pneumonia (PVAP) | - |
2402-6 | Asymptomatic bacteremic UTI (ABUTI) | - |
3066-8 | Neonatal Laboratory Confirmed Bloodstream Infection 1 (NLCBI 1) | - |
3067-6 | Neonatal Laboratory Confirmed Bloodstream Infection 2 (NLCBI 2) | - |
3068-4 | Neonatal Laboratory Confirmed Meningitis 1 (NLCM 1) | - |
3069-2 | Neonatal Laboratory Confirmed Meningitis 2 (NLCM 2) | - |
1901-8 | Not cultured | - |
1902-6 | Blood culture not done or no organisms detected in blood | - |
1903-4 | New onset/change in sputum | - |
1904-2 | New onset/worsening cough, dyspnea, tachypnea | - |
1905-9 | Other evidence of infection found | - |
1906-7 | Other signs and symptoms | - |
1907-5 | New onset or change in sputum, increased secretions or increased suctioning | - |
1908-3 | Bradycardia or tachycardia | - |
1909-1 | Occult or gross blood in stools (with no rectal fissure) | - |
1920-8 | Localized swelling | - |
1921-6 | Rales or bronchial breath sounds | - |
1922-4 | Wheezing, rales or rhonchi | - |
1923-3 | Greater than or equal to 5% bronchoalveolar lavage cells with bacteria | - |
1924-0 | Imaging test evidence of infection | - |
1925-7 | New or progressive and persistent infiltrate | - |
1926-5 | Pneumatoceles (in <=1 year old) | - |
1927-3 | One positive culture with >=100,000 cfu/ml with no more than 2 species of microorganisms | - |
1928-1 | Positive dipstick for leukocyte esterase or nitrate | - |
1929-9 | Greater than or equal to 2 positive urine cultures with >=100 cfu/ml of same uropathogen from non-voided specimen | - |
1930-7 | One positive culture with <=100,000 cfu/ml of a single uropathogen in patient being treated with an effective antimicrobial agent for UTI | - |
1931-5 | Greater than or equal to 2 positive urine cultures with >=100,000 cfu/ml with no more than 2 organisms | - |
1934-9 | Positive detection of viral antigen or antibody | - |
1935-6 | Fourfold rise in paired sera for pathogen | - |
1936-4 | Positive culture or microimmunofluorescence of Legionella species | - |
1937-2 | Legionella pneumophila serogroup 1 antigens in urine | - |
1938-0 | Fourfold rise in Legionella pneumophila antibody titer | - |
1939-8 | Matching positive blood and sputum cultures with Candida species | - |
1940-6 | Fungi or Pneumocystis carinii from lower respiratory tract specimen | - |
1941-4 | Other positive laboratory tests | - |
1942-2 | More than 15 colonies cultured from intravascular cannula tip using semi-quantitative culture method | - |
1943-0 | Positive Gram stain when culture is negative or not done | - |
1944-8 | Common commensal from >=2 blood cultures | - |
1946-3 | Organism(s) identified from pleural fluid | - |
1947-1 | Positive quantitative culture from lower respiratory tract (LRT) specimen | - |
1948-9 | Positive culture of virus or Chlamydia | - |
1949-7 | Positive PCR for Chlamydia or Mycoplasma | - |
1950-5 | Positive microimmunofluorescence test for Chlamydia | - |
1951-3 | Recognized pathogen from one or more blood cultures | - |
1952-1 | Positive culture | - |
1953-9 | Positive culture of pathogen | - |
1954-7 | Positive culture of skin contaminant | - |
1955-4 | Positive blood culture | - |
1956-2 | Histopathologic exam with abscess formation or lung parenchyma invasion by fungal hyphae | - |
1957-0 | Acute onset of diarrhea (liquid stools for >12 hours) | - |
1958-8 | Worsening gas exchange | - |
1959-6 | Apnea, tachypnea, nasal flaring with retraction of chest wall or grunting | - |
1960-4 | Pain or tenderness | - |
1962-0 | Physician institutes appropriate antimicrobial therapy | - |
1963-8 | Physician diagnosis of this event type | - |
1964-6 | Allogeneic hematopoietic stem cell transplant (allo-SCT) with grade >=3 gastrointestinal graft-versus-host disease (GI GVHD) | - |
1965-3 | Allogeneic hematopoietic stem cell transplant (allo-SCT) with diarrhea | - |
1966-1 | Positive culture from >=2 separate tissue or fluid samples from affected joint | - |
1967-9 | Incision deliberately opened or drained | - |
1968-7 | Sinus tract | - |
1971-1 | Acute pain, swelling, or tenderness of testes, epididymis, or prostate | - |
1972-9 | Urine not tested for white blood cells | - |
2320-0 | Wound (not related to vascular access) with pus or increased redness | - |
2346-5 | Daily minimum FiO2 increase >=0.20 (20 points) for >=2 days | - |
2347-3 | Daily minimum PEEP increase >=3 cm H2O for >=2 days | - |
2348-1 | Temperature >38°C or <36°C | - |
2349-9 | White blood cell count >=12,000 or <=4,000 cells/mm3 | - |
2350-2 | A new antimicrobial agent(s) is started, and is continued for >=4 days | - |
2351-1 | Criterion 1: positive culture from endotracheal aspirate without purulent respiratory secretions | - |
2352-5 | Criterion 1: positive culture from bronchoalveolar lavage without purulent respiratory secretions | - |
2353-3 | Criterion 1: positive culture from lung tissue without purulent respiratory secretions | - |
2354-1 | Criterion 1: positive culture from protected specimen brush without purulent respiratory secretions | - |
2355-9 | Criterion 2: purulent respiratory secretions plus organism(s) | - |
2356-4 | Criterion 2: organisms from sputum culture with purulent respiratory secretions | - |
2357-2 | Criterion 2: organisms from endotracheal aspirate culture with purulent respiratory secretions | - |
2358-0 | Criterion 2: organisms from bronchoalveolar lavage culture with purulent respiratory secretions | - |
2359-8 | Criterion 2: organisms from lung tissue culture with purulent respiratory secretions | - |
2360-1 | Criterion 2: organisms from protected specimen brush culture with purulent respiratory secretions | - |
2361-0 | Criterion 3: positive test for organism(s) identified from pleural fluid | - |
2362-4 | Criterion 3: positive test for lung histopathology | - |
2363-2 | Criterion 3: positive diagnostic test for Legionella species | - |
2364-0 | Criterion 3: positive diagnostic test for selected viral pathogens | - |
2403-4 | One positive culture with >=1,000 cfu/ml and <100,000 cfu/ml with no more than 2 species of microorganisms | - |
2513-0 | Bilateral infiltrates on chest x-ray | - |
2514-8 | Diffuse hemorrhage | - |
2515-5 | Nausea/vomiting | - |
2516-3 | Criterion not otherwise specified | - |
2517-1 | Pain not otherwise specified | - |
2518-9 | Rash not otherwise specified | - |
3070-0 | Common commensal from blood specimen(s) and antibiotics for >=5 days | - |
3071-8 | Recognized pathogen from cerebrospinal fluid specimen | - |
3072-6 | Common commensal from cerebrospinal fluid specimen and antibiotics for >=5 days | - |